Fiscal Year:
2001
Title:
CAD-CAM TECHNOLOGY FOR DIABETIC FOOTWEAR
Agency:
HHS
Contract:
N/A
Award Amount:
$199,143.00
Abstract:
DESCRIPTION (Adapted from the Investigator's Abstract): Gastrointestinal (GI)
ulceration and hemorrhage is a major health problem in our country representing
billions of dollars in health care costs and lost revenues from work place.
Despite sophisticated therapeutic agents, the disturbing problem of high
recurrence rate of bleeding, even after complete healing, remains. About one
third of the patients treated with traditional ulcer therapy have recurrent
hemorrhage. There is a need for developing new drugs that can arrest
hemorrhage. In our pilot work we have shown that the organic extract of Chinese
herbal preparation, Yunnan baiyao, has favorable influence on severe intestinal
syndromes produced by indomethacin, and is also effective in promoting the
healing and preventing GI ulcers in rat models. We have also shown that the
extract contains at least two potent factors that induce aggregation of human
platelets. We propose in this SBIR application to optimize methods for
extraction as well as establish the molecular identity and mode of action of
active principles that exhibit platelet aggregatory activities. We plan to
carry out biological assays specific for anti-ulcerative and anti-hemorrhagic
properties. The Phase I study will lay the foundation essential for the full
development of the active factors into anti-hemorrhagic drug in Phase II
studies.
PROPOSED COMMERCIAL APPLICATION:
The market for an effective and safe therapeutic agent to treat several types of
hemorrhagic disorder notably bleeding from esophageal varices, gastric and
duodenal ulcers will be enormous.
Principal Investigator:
Joseph L. Loomis
Small Business Information at Submission:
DIAPEDIA, LLC
1352 DEERFIELD DR STATE COLLEGE, PA 16803
EIN/Tax ID:
251858279
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No